Abstract
BackgroundMost of the disease modifying anti-rheumatic drugs (DMARDs) have cardioprotective potential and using them to achieve remission and/or low disease activity in rheumatoid arthritis (RA) importantly diminishes the cardiovascular risk...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have